BlackRock Fund Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

BlackRock Fund Advisors’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	741	–	–	﹤0.01%	4217
2016 Q3	$1K	Buy	741 +57	+8%	+$125	﹤0.01%	4243
2016 Q2	$2K	Buy	684 +64	+10%	+$150	﹤0.01%	4238
2016 Q1	$2K	Buy	620 +154	+33%	+$518	﹤0.01%	4243
2015 Q4	$2K	Buy	+466	New	+$1.88K	﹤0.01%	4312
2014 Q2	–	Sell	-6,498	Closed	-$89K	–	3909
2014 Q1	$89K	Buy	6,498 +788	+14%	+$12.8K	﹤0.01%	3598
2013 Q4	$134K	Buy	5,710 +239	+4%	+$6.5K	﹤0.01%	3530
2013 Q3	$172K	Buy	5,471 +431	+9%	+$14.3K	﹤0.01%	3426
2013 Q2	$159K	Buy	+5,040	New	+$174K	﹤0.01%	3399

Other funds holding STAB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Fund Advisors's STAB Position: Q4 2016 in Review

BlackRock Fund Advisors held its Statera Biopharma, Inc. Common Stock (STAB) position steady in Q4 2016 at 741 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

BlackRock Fund Advisors first reported a position in STAB in Q2 2013 and has held it in 9 quarters since. The position peaked at $172K in Q3 2013. 20 funds tracked by Wall St. Rank hold STAB as of Q4 2016.

BlackRock Fund Advisors held 741 shares of Statera Biopharma, Inc. Common Stock worth $1K as of Q4 2016.
BlackRock Fund Advisors left its Statera Biopharma, Inc. Common Stock share count unchanged in Q4 2016.
Statera Biopharma, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4217 holding.
BlackRock Fund Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and has held it in 9 quarters since.
BlackRock Fund Advisors's Statera Biopharma, Inc. Common Stock position peaked at $172K in Q3 2013.
20 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.